Slc2as as modifiers of the p53 pathway and methods of use

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 48/00 (2006.01) A01N 63/00 (2006.01) A61K 49/00 (2006.01) C12Q 1/00 (2006.01) C12Q 1/42 (2006.01) C12Q 1/48 (2006.01) C12Q 1/527 (2006.01) C12Q 1/68 (2006.01) G01N 33/50 (2006.01) G01N 33/53 (2006.01) G01N 33/573 (2006.01) G01N 33/574 (2006.01) G01N 33/68 (2006.01)

Patent

CA 2449425

Human SLC2A genes are identified as modulators of the p53 pathway, and thus as therapeutic targets for disorders associated with defective p53 function. Methods for identifying modulators of p53, comprising screening for agents that modulate the activity of SLC2A are provided.

Des gènes SLC2A humains on été identifiés comme des modulateurs de la voie p53, et sont donc des cibles thérapeutiques destinées à des troubles associés à une fonction p53 déficiente. L'invention concerne des procédés d'identification de modulateurs de p53, consistant à effectuer le criblage d'agents qui modulent l'activité de SLC2A.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Slc2as as modifiers of the p53 pathway and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Slc2as as modifiers of the p53 pathway and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Slc2as as modifiers of the p53 pathway and methods of use will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1598524

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.